Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Koszalin
Clinical trial register · Poland

Clinical Trials in Koszalin, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Poland and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2716 matching records held by the registry are in this view. Synced 15 Nov 2026, 03:18 UTC
2716
Studies in scope
all four open statuses
1383
Recruiting now
open to new participants
510
Lead sponsors
across recruiting studies
Top sites
Warsaw 1322 Krakow 882 Poznan 697 Gdansk 665 Lodz 621
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca28 Merck Sharp & Dohme LLC21 Hoffmann-La Roche7 Pfizer7 Janssen Research & Development, LLC4 Eli Lilly and Company2 BioNTech SE2 Bristol-Myers Squibb2 Janssen Pharmaceutica N.V., Belgium1 Daiichi Sankyo1 Shanghai Henlius Biotech1 GlaxoSmithKline1 Shanghai Junshi Bioscience Co., Ltd.1 Jiangsu HengRui Medicine Co., Ltd.1 Genmab1 Taiho Oncology, Inc.1 Can-Fite BioPharma1 Bayer1
Site location
Warsaw1322 Krakow882 Poznan697 Gdansk665 Lodz621 Wroclaw528 Lublin527 Bydgoszcz525 Katowice511 Bialystok389 Olsztyn192 Szczecin182 Rzeszów182 Gdynia168 Gliwice121 Kielce117 Torun110 Opole106 Koszalin83 Siedlce81 Zabrze71 Elblag67 Otwock56 Przemyśl55 Chorzów54 Tarnów50 Skorzewo48 Częstochowa47 Skórzewo45 Oświęcim44 Brzozów43 Konin40 Nowa Sól38 Biała Podlaska32 Bielsko-Biala32 Chrzanów31 Słupsk30 Sosnowiec28 Grudziądz28 Gda?sk28 Bytom27 Wałbrzych26 Chojnice25 Radom23 Lubin22 Piotrkow Trybunalski22 Tomaszów Mazowiecki22 Sopot22 Mysłowice21 Ostrowiec Świętokrzyski21 Nowy Targ20 Tychy20 Legnica20 Prabuty20 Późna19 Zamość19 Wroc?aw18 Nadarzyn18 Malbork17 Grodzisk Mazowiecki17 Bystra16 Wieliszew15 Trzebnica13 Sochaczew13 Świdnik13 Dębica12 ?ód?12 Plewiska11 Nowy Sącz11 Leszno10 Kłodzko10 Osielsko10 Rybnik10 Staszów10 Skierniewice9 Chęciny9 Ruda Śląska9 Bia?ystok9 Piaseczno9 Jelenia Góra9 Dąbrowa Górnicza8 Piła8 Bełchatów8 Lódz7 Siemianowice Śląskie7 Zielona Góra7 Puławy7 Knurów6 Gorlice6 Grzepnica6 Swidnica6 Cracow6 Ustroń6 ?ory6 Krosno6 Józefów6 Gorzów Wielkopolski6 Łęczna5 Karczew5 Gmina Świecie5 Dziekanów Leśny5 Wołomin5 Pabianice5 Tarnowskie Góry5 Będzin5 Ossy4 Włocławek4 Dąbrówka4 Tuszyn4 Warszawa4 Ostrołęka4 Ksawerów4 Racibórz4 Sanok4 Skawina4 Iława4 Łomianki4 Kędzierzyn-Koźle4 Ścinawa4 Wadowice3 Słomniki3 Komorniki3 Wejherowo3 Bygdoszcz3 Milówka3 Multiple Locations3 Ostrów Mazowiecka3 Gdask3 Giżycko3 Wieliczka3 Pruszków3 Płock3 Bielsk Podlaski3 Gmina Końskie2 Mrozy2 Brodnica2 Pszczyna2 Żyrardów2 Jarocin2 ??czna2 Śląskie2 Poland2 Kutno2 Glogow Wielkopolski2 Inowrocław2 Myślenice2 Rabka-Zdrój2 Krąków2 Pomorskie2 Stanisławów Pierwszy2 Warszewo2 Olkusz2 Świnoujście2 Pozna?2 Bolesławiec2 Czeladź2 B?dzin2 Maków Podhalański2 Kościan2 I?awa2 Iwaszkiewicza 52 Suchy Las2 Woj. Podkarpackie2 Łańcut2 Rzeszw2 Pi?a1 Ciechanów1 Cieszyn1 Kraków1 Wrocaw1 Tomaszow Mazowiecki1 Mielec1 Radzionków1 Rzwszow1 Krakow (Cracow)1 Swietokrzyski1 Strzelce Opolskie1 Sandomierz1 Warszawa Targówek1 Stanisławow Pierwszy Nieporet1 Raszyn1 Janki1 Mikołów1 Iwonicz-Zdrój1 Bolesławice1 Wiele1 Jasło1 Skorzewo (Poznan)1 Wodzisław Śląski1 Środa Wielkopolska1 Kobylniki1 Many Locations1 Małogoskie1 Płońsk1 Chelmie1 Działdowo1 Gryfice1 Węgrów1 Żywiec1 Janów Lubelski1 Pińczów1 Długa1 Lodzkie1 Kajetany1 Dąbrowa Tarnowska1 Cracov1 Myslowice1 Podlaski1 Wrocław1 Lodź1 L DZ1 Klinika Nowotworow Ukladu Chlonnego1 Myszków1 Zakopane1 Gniezno1 Mińsk Mazowiecki1 Libiąż1 Starogard Gdański1 Poznań1 Kraśnik1 Kwidzyn1 Kracow1 Rzeszáw1 Ostróda1 Skarżysko-Kamienna1 Dobry Lekarz1 ?cinawa1 Kalisz1 Grójec1 Wo?omin1 Chojncie1 Chełm1 Miechów1 Grudzi?dz1 Warsawawa1 Bychawa1 Piotrków1 Zawadzkie1 Poniatowa1 Ełk1 Żarów1 ?Od?1 Katowice - Ochojec1 Stupsk1 Kazimierza Wielka1 Bialystok-Podlaskie1 Naklo N. Notecią1 Stalowa Wola1 Tczew1 Toruniak1 Pozman1 Plońsk1 Żychlin1 Ostrów Wielkopolski1 Legionowo1 Polanica-Zdrój1 Glogow Mlp.1 Grodzisk Wielkopolski1 Uniwersyteckie Centrum Kliniczne1 Ód1 Mazowieckie1 Elbl?g1
All 262 locations
Target enrolment
to

Trials with a site in Koszalin

83 of 2716 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Poland
Start
Recruiting
AstraZeneca
Phase 3
1,330
Gdansk, Koszalin, Krakow, Lodz, Olsztyn, Poznan, Warsaw, Wroclaw
2026-09-15
Recruiting
AstraZeneca
Phase 3
915
Gdansk, Koszalin, Poznan, Siedlce, Skórzewo, Wroclaw
2026-07-16
Recruiting
AstraZeneca
Phase 1
40
Brzozów, Koszalin, Lublin, Olsztyn, Przemyśl
2026-03-31
Recruiting
AstraZeneca
Phase 3
2,130
Gdansk, Koszalin, Krakow, Lublin, Olsztyn, Warsaw
2026-02-03
Recruiting
Bristol-Myers Squibb
Phase 2/3
990
Krakow, Warsaw, Wieliszew, Opole, Brzozów, Gdansk, Gliwice, Koszalin
2025-12-31
Recruiting
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
NCT07218380Carcinoma, Transitional Cell, Urinary Bladder Neoplasms, Neoplasm Metastasis
DrugsVepugratinib·Pembrolizumab
Eli Lilly and Company
Phase 3
450
Bydgoszcz, Koszalin, Krakow, Skórzewo, Sosnowiec, Warsaw, Wrocaw
2025-12-12
Recruiting
Pfizer
Phase 3
800
Katowice, Koszalin, Krakow, Opole, Poznan
2025-12-11
Recruiting
Merck Sharp & Dohme LLC
Phase 2
150
Warsaw, Koszalin
2025-12-04
Recruiting
AstraZeneca
Phase 3
1,100
Koszalin, Krakow, Lodz, Olsztyn, Warsaw
2025-12-04
Recruiting
Merck Sharp & Dohme LLC
Phase 3
904
Skórzewo, Bydgoszcz, Krakow, Siedlce, Warsaw, Przemyśl, Koszalin
2025-11-26
Recruiting
A Platform Study in Non-Small Cell Lung Cancer (NSCLC)
NCT06996782Advanced or Metastatic Non-small Cell Lung Cancer
DrugsRamucirumab·Rilvegostomig·Nab-paclitaxel·Pemetrexed
AstraZeneca
Phase 1/2
152
Koszalin, Lodz, Olsztyn
2025-11-24
Recruiting
Pfizer
Phase 2/3
982
Warsaw, Olsztyn, Koszalin, Poznan, Tomaszów Mazowiecki
2025-10-03
Recruiting
AstraZeneca
Phase 1/2
283
Koszalin, Piotrkow Trybunalski, Przemyśl
2025-10-01
Recruiting
Pfizer
Phase 3
1,000
Poznan, Wroclaw, Szczecin, Koszalin, Krakow, Lublin, Rzeszów
2025-09-28
Recruiting
Janssen Research & Development, LLC
Phase 3
1,203
Bialystok, Bydgoszcz, Koszalin, Warsaw
2025-09-02
Recruiting
AstraZeneca
Phase 3
700
Gdynia, Gliwice, Koszalin, Krakow, Piotrkow Trybunalski, Poznan, Rzeszów, Warsaw
2025-08-06
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,000
Bydgoszcz, Warsaw, Bialystok, Słupsk, Olsztyn, Koszalin, Lodz
2025-07-21
Recruiting
Merck Sharp & Dohme LLC
Phase 3
477
Poznan, Warsaw, Rzeszów, Gliwice, Koszalin
2025-07-16
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
360
Poznan, Warsaw, Gdansk, Koszalin
2025-07-03
Recruiting
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
NCT06966700Breast Neoplasms, Triple Negative Breast Neoplasms, HR Low-Positive/HER2-Negative Breast Neoplasms
DrugsEpirubicin·Adriamycin·Xeloda·Paraplatin
Merck Sharp & Dohme LLC
Phase 3
2,400
Bydgoszcz, Krakow, Wałbrzych, Warsaw, Bialystok, Słupsk, Olsztyn, Koszalin
2025-06-30
Recruiting
GlaxoSmithKline
Phase 1/2
346
Brzozów, Koszalin, Warsaw
2025-06-11
Recruiting
Merck Sharp & Dohme LLC
Phase 2
144
Poznan, Warsaw, Gdansk, Koszalin
2025-05-28
Active, closed
Merck Sharp & Dohme LLC
Phase 2
96
Poznan, Warsaw, Gdansk, Koszalin
2025-05-13
Recruiting
AstraZeneca
Phase 3
1,220
Bydgoszcz, Gdansk, Koszalin, Lublin, Olsztyn, Warsaw
2025-05-06
Recruiting
Hoffmann-La Roche
Phase 3
450
?ód?, Bialystok, Konin, Koszalin, Krakow, Lublin, Późna, Rzeszów
2025-04-09
Recruiting
Merck Sharp & Dohme LLC
Phase 2
90
Poznan, Warsaw, Gdansk, Koszalin
2025-03-30
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
270
Poznan, Krakow, Warsaw, Koszalin
2025-03-25
Recruiting
AstraZeneca
Phase 3
840
Bialystok, Gdansk, Koszalin, Lodz, Olsztyn, Przemyśl, Tomaszów Mazowiecki, Warsaw
2025-03-01
Recruiting
Daiichi Sankyo
Phase 3
726
Bielsko-Biala, Koszalin, Poznan, Warsaw
2025-02-27
Recruiting
BioNTech SE
Phase 3
621
Gdansk, Katowice, Konin, Koszalin, Krakow, Lodz, Lublin, Olsztyn
2025-02-03
Recruiting
BioNTech SE
Phase 2/3
1,580
Bialystok, Bydgoszcz, Gdansk, Gliwice, Katowice, Kielce, Koszalin, Krakow
2025-01-07
Active, closed
Pfizer
Phase 3
1,035
Krakow, Bialystok, Gdynia, Koszalin, Lodz
2025-01-06
Active, closed
Genmab
Phase 3
191
Koszalin, Krakow, Lodz, Skorzewo, Warsaw
2024-11-25
Recruiting
Shanghai Henlius Biotech
Phase 3
550
Brzozów, Gdansk, Koszalin, Lodz, Lublin, Otwock, Skorzewo, Słupsk
2024-11-22
Recruiting
Pfizer
Phase 3
900
Krakow, Wroclaw, Lublin, Warsaw, Koszalin, Opole, Piotrkow Trybunalski
2024-10-22
Active, closed
Pfizer
Phase 3
609
Grudziądz, Torun, Krakow, Wroclaw, Opole, Koszalin
2024-10-21
Recruiting
Bristol-Myers Squibb
Phase 3
1,000
Konin, Poznan, Bydgoszcz, Warsaw, Koszalin, Prabuty, Lodz
2024-10-07
Recruiting
AstraZeneca
Phase 3
788
Biała Podlaska, Koszalin, Lodz, Lublin, Poznan, Radom, Warsaw
2024-08-01
Active, closed
Merck Sharp & Dohme LLC
Phase 2
272
Bydgoszcz, Warsaw, Koszalin
2024-04-10
Active, closed
Merck Sharp & Dohme LLC
Phase 1/2
230
Poznan, Bydgoszcz, Warsaw, Koszalin, Kielce
2024-03-28
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,310
Bydgoszcz, Grudziądz, Torun, Siedlce, Koszalin, Szczecin, Kielce
2023-12-31
Active, closed
Merck Sharp & Dohme LLC
Phase 2
147
Bydgoszcz, Warsaw, Koszalin, Szczecin
2023-12-26
Active, closed
Hoffmann-La Roche
Phase 3
1,050
?ód?, Bydgoszcz, Gdynia, Gliwice, Kielce, Konin, Koszalin, Lublin
2023-12-11
Active, closed
AstraZeneca
Phase 3
1,898
Bydgoszcz, Koszalin, Poznan, Rzeszów, Warsaw, Wroclaw
2023-11-21
Active, closed
AstraZeneca
Phase 3
5,511
Bialystok, Biała Podlaska, Bydgoszcz, Gdansk, Gdynia, Koszalin, Krakow, Lodz
2023-10-05
Recruiting
Hoffmann-La Roche
Phase 3
230
Bydgoszcz, Gda?sk, Gdynia, Gliwice, Konin, Koszalin, Późna, Warsaw
2023-09-08
Active, closed
Janssen Research & Development, LLC
Phase 3
420
Bydgoszcz, Koszalin, Warsaw, Wroclaw
2023-08-31
Recruiting
Study of Futibatinib in Patients With Advanced Cholangiocarcinoma With FGFR2 Fusion or Rearrangement
NCT05727176Advanced Cholangiocarcinoma, FGFR2 Fusions, Gene Rearrangement
DrugFutibatinib
Taiho Oncology, Inc.
Phase 2
120
Koszalin, Lublin, Otwock, Warsaw
2023-07-05
Recruiting
Hoffmann-La Roche
Phase 3
420
Bydgoszcz, Gdynia, Gliwice, Konin, Koszalin, Krakow, Rzeszów, Warsaw
2023-06-07
Recruiting
Hoffmann-La Roche
Phase 3
200
Gda?sk, Koszalin, Warsaw
2023-06-01
Active, closed
Hoffmann-La Roche
Phase 2
204
Koszalin, Krakow, Późna, Warsaw
2023-04-13
Recruiting
AstraZeneca
Phase 3
4,300
Bialystok, Grudziądz, Koszalin, Lodz, Lublin, Opole, Poznan, Racibórz
2023-03-31
Recruiting
Can-Fite BioPharma
Phase 3
471
Koszalin, Krakow, Mysłowice, Przemyśl, Warsaw, Wroclaw
2023-03-15
Active, closed
Merck Sharp & Dohme LLC
Phase 3
377
Warsaw, Olsztyn, Koszalin
2023-02-14
Active, closed
AstraZeneca
Phase 3
1,350
Bydgoszcz, Bystra, Grudziądz, Kielce, Koszalin, Olsztyn, Poznan, Przemyśl
2022-12-29
Active, closed
Eli Lilly and Company
Phase 3
8,000
Gdynia, Koszalin, Lodz, Opole, Oświęcim, Siedlce, Torun, Warsaw
2022-10-04
Active, closed
Hoffmann-La Roche
Phase 3
922
Gdansk, Konin, Koszalin, Opole, Pi?a, Późna, Rzeszów, Warsaw
2022-07-18
Active, closed
AstraZeneca
Phase 3
1,051
Bydgoszcz, Gdansk, Koszalin, Poznan, Siedlce, Tomaszów Mazowiecki, Warsaw
2022-02-07
Recruiting
Merck Sharp & Dohme LLC
Phase 1
830
Poznan, Warsaw, Gdansk, Koszalin
2021-12-17
Active, closed
AstraZeneca
Phase 3
927
Bialystok, Biała Podlaska, Bydgoszcz, Koszalin, Lublin, Rzeszów, Warsaw
2021-10-25
Active, closed
AstraZeneca
Phase 3
732
Bialystok, Gdansk, Gdynia, Konin, Koszalin, Lodz, Tomaszów Mazowiecki, Warsaw
2021-10-18
Active, closed
AstraZeneca
Phase 3
315
Bydgoszcz, Gdynia, Koszalin, Lodz, Poznan, Rzeszów, Tomaszów Mazowiecki, Warsaw
2021-06-30
Active, closed
Merck Sharp & Dohme LLC
Phase 3
808
Poznan, Siedlce, Warsaw, Przemyśl, Wrocław, Koszalin
2021-04-21
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,688
Konin, Poznan, Bydgoszcz, Radom, Warsaw, Koszalin
2021-04-14
Active, closed
Jiangsu HengRui Medicine Co., Ltd.
Phase 3
496
Gdynia, Grudziądz, Kobylniki, Koszalin, Krakow, Poznan, Warsaw, Wroclaw
2021-03-18
Active, closed
AstraZeneca
Phase 3
1,371
Gdynia, Konin, Koszalin, Lodz, Lublin, Olsztyn, Poznan
2021-01-28
Active, closed
AstraZeneca
Phase 1/2
245
Bydgoszcz, Koszalin, Lodz, Lublin
2020-12-28
Active, closed
Janssen Pharmaceutica N.V., Belgium
Phase 3
691
Bydgoszcz, Elblag, Gdansk, Gdynia, Kielce, Koszalin, Lodz, Radom
2020-11-12
Active, closed
Bayer
Phase 4
654
Krakow, Wroclaw, Lublin, Warsaw, Koszalin
2020-11-09
Active, closed
AstraZeneca
Phase 3
866
Bydgoszcz, Koszalin, Krakow, Lodz, Rzeszów, Warsaw, Wroclaw
2020-07-24
Active, closed
AstraZeneca
Phase 3
1,012
Bydgoszcz, Gdansk, Koszalin, Lodz, Olsztyn, Poznan, Rzeszów, Torun
2020-07-13
Active, closed
Shanghai Junshi Bioscience Co., Ltd.
Phase 3
530
Gdansk, Koszalin, Krakow, Mysłowice, Poznan, Skórzewo, Warsaw
2020-06-29
Active, closed
AstraZeneca
Phase 2
452
Gdansk, Konin, Koszalin, Krakow, Warsaw
2020-06-03
Active, closed
Merck Sharp & Dohme LLC
Phase 3
520
Krakow, Siedlce, Koszalin
2020-05-19
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
450
Warsaw, Gdansk, Koszalin
2019-12-19
Recruiting
Merck Sharp & Dohme LLC
Observational
1,065
Warsaw, Gdansk, Koszalin
2019-12-19
Active, closed
Janssen Research & Development, LLC
Phase 3
2,517
Bydgoszcz, Koszalin, Krakow, Warsaw, Wroclaw
2019-06-11
Active, closed
AstraZeneca
Phase 3
1,063
Bialystok, Gdansk, Grudziądz, Koszalin, Krakow, Olsztyn, Ostrołęka, Poznan
2018-11-16
Active, closed
AstraZeneca
Phase 3
1,246
Bialystok, Gdansk, Grudziądz, Koszalin, Krakow, Olsztyn, Poznan, Radom
2018-09-27
Active, closed
AstraZeneca
Phase 3
1,018
Bialystok, Gdansk, Grudziądz, Koszalin, Piotrkow Trybunalski, Poznan, Warsaw, Wroclaw
2018-05-14
Active, closed
Janssen Research & Development, LLC
Phase 3
211
Chorzów, Koszalin, Lodz, Lublin, Warsaw
2018-04-17
Recruiting
A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
NCT03460977Metastatic Castration Resistant Prostate Cancer (mCRPC), Small Cell Lung Cancer (SCLC), Follicular Lymphoma (FL)
DrugsMevrometostat·Xtandi·Itraconazole·Enzalutamide
Pfizer
Phase 1
453
Bydgoszcz, Koszalin, Krakow, Rzeszów, Warsaw
2018-04-17
Active, closed
AstraZeneca
Phase 3
669
Bialystok, Grudziądz, Koszalin, Lublin, Mrozy, Warsaw, Wroclaw
2017-01-02
Rows per page Showing 1–83 of 83
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Polish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 15 November 2026. https://priyalifescience.com/clinical-trials-poland/city/koszalin

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Poland and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,716 studies in total at the last sync on 15 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 83 of those studies with a site in Koszalin.

How many clinical trials are recruiting in Koszalin?

45 of the 83 studies on this page are recruiting new participants as of the 15 Nov 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 38 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Koszalin), 83 studies
PhaseStudiesRecruitingShare
Phase 3582869.9%
Phase 29410.8%
Phase 1/2869.6%
Phase 1333.6%
Phase 2/3333.6%
Observational111.2%
Phase 4101.2%

Most active sponsors

Lead sponsors with the most studies (Koszalin)
Lead sponsorStudiesRecruiting
AstraZeneca2812
Merck Sharp & Dohme LLC2113
Hoffmann-La Roche74
Pfizer75
Janssen Research & Development, LLC41
BioNTech SE22
Bristol-Myers Squibb22
Eli Lilly and Company21
Bayer10
Can-Fite BioPharma11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.